Dr. Stewart Graham

Dr. Stewart Graham, a neuroscientist and metabolomicist from N.Ireland, completed his B.Sc. in Biochemistry, M.Sc. in Bimolecular Structure and Function, and Ph.D. in Metabolomics at QUB between 2000-2009. During his post-doc training at QUB from 2009-2011, he focused on identifying diagnostic markers of food fraud using metabolomics while also conducting research on transgenic mouse models of Alzheimer’s disease, securing funding from the Alzheimer’s Research Trust UK (ARUK).  From 2011-2014, he served as an ARUK fellow, conducting groundbreaking research on post-mortem human brains from Alzheimer’s patients using high-resolution metabolomics platforms.  In 2014, Dr. Graham assumed the role of Director of Metabolomics Research at Beaumont Health (now Corewell Health). He was appointed Assistant Professor at OUWB in 2016 and was promoted to Associate Professor in July 2020.

He also holds the inaugural John and Marilyn Bishop Foundation Endowed Chair and Director of Alzheimer’s Disease Research at Corewell Health since September 2020. His research interests are focused on neurodegenerative diseases, particularly Alzheimer’s, Parkinson’s, and Huntington’s disease, with >90 peer-reviewed publications. His research is supported by various agencies, including NIH, the Alzheimer’s Association, and the Michael J. Fox Foundation.  His primary goals as a scientist are to identify early diagnostic biomarkers for neurodegenerative diseases and gain a deeper understanding of their underlying causes.